Skip to main content

Table 6 Change in cardiovascular and diabetic drug therapy 1 year post scan based on having a normal or abnormal stress perfusion cardiac magnetic resonance (CMR) examination

From: Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study

 1 year change in medications 
Normal CMR (n = 36)Abnormal CMR (n = 27)p
Anti-hypertensives
 Beta-blockers+2+40.39
 ACE inhibitor+1+30.80
 Calcium channel blockers−1+40.03*
 Alpha-blockers0+20.76
 Diuretics0+30.07
 ARB+101.00
Lipid-modifying agents
 Statin+1+80.01*
 Fibrates001.00
Anti-hyperglycaemic agents
 Acarbose−1+10.68
 Sulfonylureas001.00
 SGLT-2 inhibitor+2+30.64
 Metformin+1+11.00
 DDP-4 inhibitor+2−10.23
 Insulin0+10.68
 Pioglitazone+3+21.00
Anti-platelet agents
 Clopidogrel0+80.001*
 Aspirin0+12< 0.001*
  1. Abnormal stress CMR was defined as having a stress perfusion defect and/or infarct
  2. ACE angiotension converting enzyme, ARB angiotensin receptor blocker, SGLT-2 sodium-glucose co-transport 2 inhibitor, DDP-4 dipeptidyl peptidase-4
  3. *p < 0.05